Switch to the dark mode that's kinder on your eyes at night time.

Switch to the light mode that's kinder on your eyes at day time.

Switch to the dark mode that's kinder on your eyes at night time.

Switch to the light mode that's kinder on your eyes at day time.

in Health

Psoriasis drug shows promise for treating childhood diabetes

by Editor July 30, 2024, 1:11 pm 1.8k Views

Primary and secondary metabolic outcome measures. a, Geometric ratio of intervention (ustekinumab) over control (placebo) over 52 weeks. b, Adjusted AUC C-peptide over 52 weeks by treatment group. c, HbA1c over 52 weeks by treatment group. d, Mean daily exogenous insulin use adjusted by body weight over 52 weeks by treatment group. e, IDAA1c over 52 weeks by…

Read the full article